Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

Université de Montréal

$22,100.00

Structural study of the disaggregation of polyglutamines involved in neurodegenerative diseases

FY 2008-09

Summary
Inclusion of polyglutamine segments in brain proteins lead to neurodegenerative diseases such as Huntington's disease and several forms of ataxias. The polyglutamine chains aggregate or form oligomers rendering the proteins insoluble and non-functional. To counter this phenomenon or to prevent it, several molecules with disaggregating potential can be added. However, the mechanism of action of the disrupting molecules remains unknown. This is due to the difficulty of synthesising the polyglutamines, to their lack of solubility at normal pH and to the difficulty to differentiate between glutamines at different positions in the chain. In order to overcome these problems, modern chemical techniques such as solid phase peptide synthesis, polarized optical microscopy, differential light scattering as well as deuterium and solid state NMR spectroscopy will be used to characterize the aggregation/disaggregation process in the solution and solid phases, identify binding sites and study kinetics. Our model will consist of synthetic polyglutamines of 15 residues or more interacting with disrupting agents of different sizes and chemical structures. Measured structural parameters will be used to construct a molecular model of the interaction. We expect that the structural information obtained in this study will lead to the rationale design of potent molecules acting on the polyglutamine aggregates.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
327342-2006
Name nom
Boulanger, Yvan
Department département
Radiologie, radio-oncologie et médecine nucléaire
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2006
Award amount
22100
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
26
Committee name en
Anal. & Phys. Chemistry
Committee name fr
Chimie analytique et physique
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
5403
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Proteins and peptides, amino acids
Research subject fr
Protéines et peptides, acides aminés
Partie
3
Nb partie
3
Application title
Structural study of the disaggregation of polyglutamines involved in neurodegenerative diseases
Keyword
NA
Application summary
Inclusion of polyglutamine segments in brain proteins lead to neurodegenerative diseases such as Huntington's disease and several forms of ataxias. The polyglutamine chains aggregate or form oligomers rendering the proteins insoluble and non-functional. To counter this phenomenon or to prevent it, several molecules with disaggregating potential can be added. However, the mechanism of action of the disrupting molecules remains unknown. This is due to the difficulty of synthesising the polyglutamines, to their lack of solubility at normal pH and to the difficulty to differentiate between glutamines at different positions in the chain. In order to overcome these problems, modern chemical techniques such as solid phase peptide synthesis, polarized optical microscopy, differential light scattering as well as deuterium and solid state NMR spectroscopy will be used to characterize the aggregation/disaggregation process in the solution and solid phases, identify binding sites and study kinetics. Our model will consist of synthetic polyglutamines of 15 residues or more interacting with disrupting agents of different sizes and chemical structures. Measured structural parameters will be used to construct a molecular model of the interaction. We expect that the structural information obtained in this study will lead to the rationale design of potent molecules acting on the polyglutamine aggregates.